• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Harvard Bioscience Inc. (HBIO)

    -NasdaqGM
    5.21 Down 0.03(0.57%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:5.24
    Open:5.25
    Bid:5.21 x 2200
    Ask:5.22 x 100
    1y Target Est:7.78
    Beta:1.65
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:5.14 - 5.25
    52wk Range:3.68 - 5.93
    Volume:40,804
    Avg Vol (3m):81,321
    Market Cap:168.90M
    P/E (ttm):113.26
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HBIO

    Comparison

    Symbol% ChgMkt Cap
    HBIODown 0.57%168.90M
    BDXDown 1.59%26.51B
    BIODown 0.30%3.31B
    TMODown 2.15%50.13B

    Key Statistics

    Forward P/E (1 yr):15.32
    P/S (ttm):1.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.26
    Quarterly EPS Est (Dec-14) :0.09
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):2.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Harvard Bioscience, Inc. develops, manufactures, distributes, and markets scientific instruments, systems, and lab consumables used in life science research. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback